Table 1 The main clinical and laboratory features of 32 healthy subjects and 37 patients diagnosed with CVST

Age (years)

35.15 ± 11.4

34.27 ± 9.49

Male (n, %)

22(65.6%)

25(67.6%)

WBC (× 10⁹)

6.15 ± 1.40

7.38 ± 2.94*

Neutrophils (%)

58.08 ± 10.75

70.14 ± 10.53*

Monocytes (%)

35.63 ± 9.59

21.10 ± 9.36*

Lymphocytes (%)

4.35 ± 1.71

6.93 ± 2.64*

Esoinophils (%)

1.84 ± 1.14

1.34 ± 1.60

Basophils (%)

0

0.46 ± 0.97

Erythrocytes(× 10¹²/L)

4.62 ± 0.41

4.30 ± 0.87

Hg (g/L)

136.55 ± 15.24

124.43 ± 26.92*

PLT (× 10⁹)

237.37 ± 62.24

224.87 ± 97.80*

PT (s)

10.99 ± 0.40

13.97 ± 4.70*

APTT (s)

34.75 ± 3.45

35.94 ± 17.88

D-dimer (g/L)

0.05 ± 0.03

1.55 ± 4.41*

Fibrinogen (mg/L)

2.61 ± 0.75

3.97 ± 2.24*

Thrombosed sinus and veins

 Superior sagittal sinus

–

12 (32.4)

 Transverse sinus

–

6 (16.2)

 Sigmoid sinus

–

6 (16.2)

 Straight sinus

–

4 (10.8)

 Deep venous system

–

4 (10.8)

 Jugular vein

–

4 (10.8)

 Perficial venous system

–

12 (32.4)

 2 sinuses involved

–

10 (27.0)

Treatments

 Surgery

–

17(45.9)

 Non-surgery

–

20(54.1)